LeMaitre Vascular stock hits 52-week low as analysts hold
AD HOC NEWS
LeMaitre Vascular (LMAT) reached a new 52-week low of USD 78.22, despite analysts holding an average price target of USD 110.60. The company's second-quarter revenue of USD 70.38 million missed consensus estimates, as did diluted earnings per share, leading to a focus on execution against expectations. Despite the miss, revenue grew by 9.60% year-over-year, and the company provided positive 2026 full-year sales and earnings per share guidance.
Read the full story
This is a short summary. The complete article is published by AD HOC NEWS.
Headline and summary aggregated from public news feeds. For information only — not financial advice.